- Home
- TOWN vs DNLI Comparison
TOWN vs DNLI Comparison
Compare TOWN & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOWN
- DNLI
- Stock Information
- Founded
- TOWN 1998
- DNLI 2013
- Country
- TOWN United States
- DNLI United States
- Employees
- TOWN N/A
- DNLI N/A
- Industry
- TOWN Major Banks
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TOWN Finance
- DNLI Health Care
- Exchange
- TOWN Nasdaq
- DNLI Nasdaq
- Market Cap
- TOWN 2.6B
- DNLI 2.1B
- IPO Year
- TOWN 1999
- DNLI 2017
- Fundamental
- Price
- TOWN $36.11
- DNLI $15.57
- Analyst Decision
- TOWN Buy
- DNLI Strong Buy
- Analyst Count
- TOWN 2
- DNLI 15
- Target Price
- TOWN $40.50
- DNLI $33.62
- AVG Volume (30 Days)
- TOWN 332.7K
- DNLI 1.9M
- Earning Date
- TOWN 10-22-2025
- DNLI 08-11-2025
- Dividend Yield
- TOWN 2.99%
- DNLI N/A
- EPS Growth
- TOWN 14.10
- DNLI N/A
- EPS
- TOWN 2.30
- DNLI N/A
- Revenue
- TOWN $741,828,000.00
- DNLI N/A
- Revenue This Year
- TOWN $22.60
- DNLI N/A
- Revenue Next Year
- TOWN $18.53
- DNLI $802.87
- P/E Ratio
- TOWN $15.67
- DNLI N/A
- Revenue Growth
- TOWN 11.04
- DNLI N/A
- 52 Week Low
- TOWN $29.43
- DNLI $10.57
- 52 Week High
- TOWN $38.28
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- TOWN 49.51
- DNLI 57.95
- Support Level
- TOWN $35.71
- DNLI $14.52
- Resistance Level
- TOWN $37.02
- DNLI $16.20
- Average True Range (ATR)
- TOWN 0.72
- DNLI 0.70
- MACD
- TOWN -0.08
- DNLI 0.00
- Stochastic Oscillator
- TOWN 48.04
- DNLI 69.27
About TOWN TowneBank
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.